Technology

SerumDPT has created the first device enabling real-time isolation of serum from drawn blood. Working at commercially acceptable scale, draw time, and cost, and eliminating the need to centrifuge, SerumDPT’s breakthrough solution provides a product that is ideal for emergency room situations, point-of-care (POC) testing, field-based applications, and more.

patent-icon

Patents
Pending

Patent pending blood separation tube for use when test results are needed quickly or automated equipment is unavailable.

vial-icon

No Centrifuge Necessary

SerumSTAT utilizes a low pressure filtration column process to eliminate the need for centrifugation.

microscope-icon

Clinically
Tested

Technology has been validated in a clinical environment with performance comparable to standard blood collection tubes & centrifugation.

minute-icon

1-Minute
Serum

Serum Stat delivers 0.25ml of serum from 2cc of drawn blood in 75 seconds.

syringe-icon

Available for Evaluation

SerumSTAT is available for evaluation. Contact us for more information.

Demo

Leadership Team

team-stats-doublesize

coco

Jean “Coco” Montagu

CEO

Coco Montagu is a serial entrepreneur and technical innovator who has been awarded 46 US patents.

  • Founder and president of Decision Biomarkers
  • Vice President of Advanced Technology at Affymetrix
  • Co-founder of Genetic MicroSystems
  • Founder and Chairman of General Scanning
  • MS/BS – MIT
  • Founder of Mechanics for Electronics
bill

Bill Bell

CSO

Bill Bell is an engineer and electronic artist who has been awarded 5 patents.

  • Communications Security Engineer at Technical Communications Corp
  • Computer Systems Engineer at Unisys Corp
  • AB in Physics – Princeton University
herman

Herman de Weerd

Director, Engineering

Herman de Weerd has over 40 years of experience in biotech and aerospace instrumentation engineering.

  • AVANTRA® Biomarker Workstation and related products
  • Microdot slide ArrayReader®
  • ScanArray 2000
  • Automated production machinery for manufacturing disposable devices
darren

Darren Lee

Chief Marketing Officer

  • VP of Marketing at Transplant Genomics Inc
  • VP of Marketing & Business Dev
    at Nabsys
  • VP of Tissue Dx Bus Segment at Caliper/PKI
  • SVP of Corporate Development
    at PrimeraDx
  • Executive roles in PKN/ABI
    at PKI
stan

Dr. Stan Rose

Chief Business Officer

  • President & CEO of Transplant Genomics Inc
  • Director of Nabsys, Invera, and TGI
  • CEO of NimbleGen & Roche/NimbleGen
  • COO of Genetic MicroSystems/Affymetrix
  • PCR Business Director at PKN/ABI
  • BA – Cornell University
  • PhD – MIT